Safety and efficacy of over 7 years of etanercept therapy in a global population of patients with rheumatoid arthritis

被引：0
|
作者：
Lebwohl, M
Gottlieb, A
Wallis, W
Zitnik, R
机构：
[1] Mt Sinai Sch Med, New York, NY USA
[2] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, New Brunswick, NJ USA
[3] Amgen Inc, Thousand Oaks, CA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2005年 / 52卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：P195 / P195
页数：1
相关论文
共 50 条
  • [1] Global safety of over 7 years of etanercept (Enbrel®) therapy in patients with rheumatoid arthritis
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Baumgartner, SW
    Tindall, E
    Kalden, J
    Whitmore, JB
    Tsuji, W
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S566 - S566
  • [2] Efficacy and Safety of Etanercept in Rheumatoid Arthritis Patients over 75 Years Old
    Kodama, Satoru
    Ito, Satoshi
    Murasawa, Akira
    Nakazono, Kiyoshi
    Kobayashi, Daisuke
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S207 - S207
  • [3] Global safety and efficacy of more than 5 years of etanercept therapy in rheumatoid arthritis
    Lebwohl, M
    Gottlieb, A
    Wallis, W
    Zitnik, R
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P142 - P142
  • [4] Safety and efficacy of over 9 years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe
    Klareskog, L.
    Moreland, L. W.
    Cohen, S. B.
    Kalden, J. R.
    Wajdula, J.
    Chon, Y.
    Lin, S.
    Baumgarter, S. W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 177 - 177
  • [5] Safety and efficacy of over 8 years of continuous etanercept therapy in patients with rheumatoid arthritis in north america and Europe
    Klareskog, L.
    Moreland, L. W.
    Cohen, S. B.
    Kalden, J. R.
    Wajdula, J.
    Chon, Y.
    Baumgartner, S. W.
    Tsujis, W. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 326 - 326
  • [6] The safety and efficacy of over seven years of continuous etanercept therapy in patients with rheumatoid arthritis in North America and Europe
    Klareskog, L
    Moreland, LW
    Cohen, SB
    Baumgartner, SW
    Tindall, EA
    Kalden, JR
    Whitmore, JB
    Tsuji, WH
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 410 - 410
  • [7] Safety of over 8 years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis
    Lovell, D. L.
    Giannini, E. H.
    Wallace, C. A.
    Ilowite, N. T.
    Reiff, A. O.
    Chon, Y.
    Lin, S.
    Baumgarter, S. W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 112 - 112
  • [8] Etanercept Therapy in Rheumatoid Arthritis: Efficacy and Safety
    Ilic, Tatjana
    Milic, Biljana
    Celic, Dejan
    Vuckovic, Biljana
    Mitic, Igor
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2013, 141 (7-8) : 495 - 502
  • [9] Efficacy and safety of over 7 years of etanercept (Enbrel®) therapy in north American patients with early and long-standing rheumatoid arthritis.
    Weinblatt, ME
    Genovese, MC
    Moreland, LW
    Bathon, JM
    Kremer, JM
    Fleischmann, RM
    Schiff, MH
    Whitmore, JB
    White, B
    [J]. ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S184 - S184
  • [10] Global safety and efficacy of more than 5 years of etanercept (ENBREL®) therapy in rheumatoid arthritis.
    Moreland, LW
    Cohen, SB
    Klareskog, L
    Burge, DJ
    [J]. ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S125 - S125
12345